(x2 = 9.6; p < 0.0001) in goitrous disease (median thyroid volume 36 ml). The specific lysis of 30% (median; 95% confidence limit 23.9\p=n-\32.9) in non-goitrous thyroiditis patients was significantly higher than in goitrous patients (16.9%; 95% confidence limit 13.2\p=n-\20. 4 Thyroid peroxidase antibodies were more frequently positive at 82% and 91%, respectively, titer levels being slightly higher in goitrous (median 7 IO9 mU/1) than in non-goitrous thyroiditis (median 2.1 109mU/l) (p < 0.05) (Fig. 3) . Thyrotropin binding-inhibiting antibodies were detectable in only three patients with an atrophie gland and negative in all those with a hypertrophie gland. Similarly, antibodies that block the TSH-induced cAMP increase (TB-ab) were positive in only a small number of patients: four with non-goitrous and one with goitrous disease (Table 1) .
Discussion
Although the pathogenetic mechanism is an auto¬ immune process in both goitrous (Hashimoto's thy¬ roiditis) and atrophie thyroiditis (primary myxedema), it remains unclear why the gland enlarged in some immune thyroiditis patients and remained normal or atrophie in others. Histologically, atrophie autoimmune thyroiditis involves progressive shrinking of the thyroid gland, loss of epithelium, lymphocytic infiltration and replacement of the glandular structure by fibrous tissue. It has been suggested, therefore, that thyroid cell destruction is initiated by antibody-and cell-mediated mechanisms. We described recently a 51Cr release assay with human thyroid cells for measurement of ADCC in autoimmune thyroiditis (11 (17) .
In Hashimoto's thyroiditis, infiltrating lymphocytes consist predominantly of cytotoxic cells, which raises the question of the role of T-cell-mediated cytotoxicity in thyroid cell destruction (18) (19) (20) (21) (22) . CD8+ T-cell clones, isolated from infiltrating lymphocytes, were found to express natural killer cell activity (20, 21 
